Home » Third Wave, Applied Biosystems Sign $80M Japanese Deal. So Why Aren't They Telling Anyone?

Third Wave, Applied Biosystems Sign $80M Japanese Deal. So Why Aren't They Telling Anyone?

Aug 11, 2000
Premium

Third Wave and Applied Biosystems recently won a contract to jointly develop SNP tests for a Japanese government project, but for some still unknown reason the deal is very hush-hush.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Try the Other Version

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

You Do Your Way

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

CRISPR Discussions

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

This Week in Science

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

What's Popular?

In Informatics

  1. Stanford-Developed Approach Allows for More Private Analysis of Human Genomes

  2. Geneformics Sees Lossless Compression as Answer to Cloud Genomics

    Premium

  3. CHOP to Head NIH-Backed Data Center for Pediatric Cancer Research

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.